March 2015 Analysis

Pages

Corporate Financing Analysis - High Yield Corporate Bond Market In Good Health - 30 MAR 2015

Reaffirming our view that high yield corporate bond activity will come out on top against activity in the investment grade bond market in 2015, Canada-based developer and marketer of medications Valeant Pharmaceuticals has sold the largest syndicated junk bond deal to have ever been completed by a Canadian company, and the largest from a firm in the healthcare sector globally.

READ FULL ARTICLE

Corporate Financing Analysis - Euro Weakness Inviting Corporate Raiders To Europe - 23 MAR 2015

With the local currency showing weakness, European companies, which are relatively cheap, have become a favourite target of deal-makers from overseas. Indeed, back at the start of the year, BMI noted that overseas deal-making was in vogue in 2015 as boardrooms attempted to tackle diminishing growth prospects at home by making acquisitive growth deals overseas. More specifically, Europe is the...

READ FULL ARTICLE

Pages